Interactive effects of blood–brain barrier breakdown and Alzheimer's disease biomarker status on cognitive decline in older adults without dementia
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70910 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Lauren Edwards und 10 weiteren Autor:innen. Beteiligte Einrichtung: San Diego State University/University of California San Diego Joint Doctoral Program in Clinical Psychology, San Diego, California, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Cognitive Dysfunction, Alzheimer Disease, Receptor, Platelet-Derived Growth Factor beta. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swedish Alzheimer Foundation, NIA NIH HHS, Alzheimer's Association.
Themen: Gerontologische Pflege, Demenz
Abstract (Originalsprache)
INTRODUCTION Some research suggests that blood–brain barrier (BBB) integrity is altered in Alzheimer's disease (AD). Few studies have examined markers of BBB integrity and their interactions with AD risk factors on multi‐domain cognition. METHODS 83 older adults without dementia underwent lumbar puncture, apolipoprotein E (APOE) genotyping, and neuropsychological testing with up to 5 years of follow‐up. Soluble platelet‐derived growth factor receptor beta (sPDGFRβ) was measured in cerebrospinal fluid. RESULTS Higher baseline sPDGFRβ was associated with better cross‐sectional attention, visuospatial, and executive functioning, but with steeper longitudinal decline in executive function. When considering AD risk status, higher sPDGFRβ was associated with faster longitudinal decline in all cognitive domains in biomarker‐positive relative to biomarker‐negative individuals and in language in APOE ɛ4‐positive relative to ɛ4‐negative individuals. DISCUSSION Elevated sPDGFRβ may increase risk of cognitive decline, particularly in individuals with a higher risk for AD. Future studies should explore mechanisms that contribute to these relationships. Highlights Cerebrospinal fluid (CSF) soluble platelet‐derived growth factor receptor beta (sPDGFRβ) is a promising marker of blood–brain barrier (BBB) integrity. Higher sPDGFRβ was cross‐sectionally associated with better cognition at baseline. Higher sPDGFRβ was longitudinally associated with steeper decline in cognition, particularly among amyloid beta (Aβ) 42/Aβ40+ individuals. CSF concentration of sPDGFRβ may predict cognitive decline in those with increased dementia risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- San Diego State University/University of California San Diego Joint Doctoral Program in Clinical Psychology, San Diego, California, USA.
- Department of Psychiatry, University of California, La Jolla, California, USA.
- Research Service, VA San Diego Healthcare System, San Diego, California, USA.
- Department of Neurosciences, University of California, La Jolla, California, USA.
- Department of Pathology, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
- Leonard Davis School of Gerontology, University of Southern California, Los Angeles, California, USA.
ORCID-Profile: Lauren Edwards
Förderung
- Swedish Alzheimer Foundation
- NIA NIH HHS
- Alzheimer's Association
- European Union Joint Program for Neurodegenerative Disorders
- NIA/NIH
- Hjärnfonden
- NIH P30
- the Swedish Research Council
Zitieren
APA
Edwards, L., Gonzalez, A. I., Thomas, K. R., Smirnov, D. S., Brenner, E. K., Nation, D. A., Chang, F., Blennow, K., Salmon, D. P., Galasko, D., & Bangen, K. J. (2025). Interactive effects of blood–brain barrier breakdown and Alzheimer's disease biomarker status on cognitive decline in older adults without dementia. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70910
Vancouver
Edwards L, Gonzalez AI, Thomas KR, Smirnov DS, Brenner EK, Nation DA, et al. Interactive effects of blood–brain barrier breakdown and Alzheimer's disease biomarker status on cognitive decline in older adults without dementia. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70910
BibTeX
@article{Edwards2025,
author = {Edwards, Lauren and Gonzalez, Amanda I and Thomas, Kelsey R and Smirnov, Denis S and Brenner, Einat K and Nation, Daniel A and Chang, Fini and Blennow, Kaj and Salmon, David P and Galasko, Douglas and Bangen, Katherine J},
title = {Interactive effects of blood–brain barrier breakdown and Alzheimer's disease biomarker status on cognitive decline in older adults without dementia},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70910}
}
EUVIMED